Aspirin Reduces COVID-19 Mortality: Investigator's Insights
Dr Jonathan Chow reviews study findings that patients with COVID-19 taking low-dose aspirin had reduced risk for use of ICU, mechanical ventilation, and of death.
Principal investigator Jonathan Chow, MD, assistant professor of anesthesiology at the University of Maryland School of Medicine, highlights study results and discusses possible mechanisms.
For details of Dr Chow's study, see: Low-dose Aspirin Reduces Risk of COVID-19 Mortality in Hospitalized Patients.
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.
Recent Videos
Related Content
